Pharma's Market
SPECIAL REPORT
MOST SHARED
- Greece to Leave Euro Zone on June 18: Wealth Manager
- European Firms Plan for Greek Unrest and Euro Exit
- Banks Recapitalization Is a 'Necessary Evil': Strategist
- Euro Rallies as Greece's Pro-Bailout Parties Gain Favor
- Italy 2-Year Borrowing Costs at Peak Since December
- Blair Says Feared Provoking British Media Wrath
- Europe’s Stronger Powers Must Reveal Plans: Ex-BoE Official
- Oil and Gas Sectors Power Aveva Profit Lift
- Newedge to Leave Greek Stock Market
- How Boaz Weinstein and Hedge Funds Outsmarted JPMorgan
- A New Look at the ‘New Poor’
- Six Pack: Beer Buzz of the Week
- Greek Exit Could Trigger 50% Fall in Euro Stocks: Analyst
- Under Pressure, FHA Skews to Wealthier Home Buyers
- Big Stock Upside for Hudson City Deal: Analyst
- 5 High-Yield Stocks Ready to Boost Dividends
- Yoshikami: Four Things You Need to Know About Gold Now
- Steinbock: The Euro Zone Endgame Begins
- Option Bulls Take Another Shot on Idenix
- Public Pensions Faulted for Bets on Rosy Returns
- Greece to Leave Euro Zone on June 18: Wealth Manager
- Italy 2-Year Borrowing Costs at Peak Since December
- Euro Bond Wins Supporters, but Details Remain Vague
- German, UK Bond Yields Will Go Even Lower
- Labor Board Member Resigns Over Leak to GOP Allies
- Banks Recapitalization Is a 'Necessary Evil': Strategist
- Loan Scheme Launches for Youth Business Start-Ups
- Southern Europeans Wire Cash to Safer North
RSS FEED
Regis Rages Against Pfizer
Text Size 
Reporter
OK. I have to put aside the fact that he went to Notre Dame and is a diehard Fighting Irish fan (Go 'SC!), but Regis' trademark rant against Pfizer [PFE
Loading...
()
] on "Fast Money" yesterday is too good not to blog it.
Reege said what a lot of investors are probably thinking.
"I'm so sick and tired of hearing what a great pharmaceutical (company) it is. When is the stock going to move?" he shouted, pounding the table for emphasis.
In PFE's defense, the stock is up about four bucks since March. But it's worth about a third of what it was valued at around the start of this decade. (Pfe 10-year [PFE
Loading...
()
])
To try to increase shareholder value, Pfizer's buying Wyeth [WYE
Loading...
()
]. But yesterday WYE suffered a bit of a setback with the FDA delaying a decision on whether to approve a new-and-improved version of a blockbuster vaccine. When PFE announced the WYE deal earlier this year it cut its attractive dividend in half. But in a research note to clients today, Deutsche Bank analyst Barbara Ryan predicts the company may raise the dividend by 15-25 percent in December. "The return of cash to shareholders through dividends will continue to be important, and probably generous, but it is unlikely to be sustained at the historic ratios of the past, and is already moving down," Ryan says. (Note: DB owns at least one percent of PFE shares, makes a market in the stock and has done and wants to do more investment banking for the firm.)
On "Fast Money" Philbin said he essentially couldn't care less about the PFE dividend. Easy for him to say, I guess, since he doesn't need a dividend check to help make ends meet.
 |
Trent Bigelow USC football |
My advice?
Regis, if you're looking for a better return take the Trojans against the Irish.
Fight On!
Questions? Comments? and follow me on Twitter at mhuckman
Data is a real-time snapshot *Data is delayed at least 15 minutes
